Thierry Delair
Corporate Officer/Principal at Defymed SAS
Profile
Thierry Delair is currently a Professor at Université Claude Bernard Lyon 1 and a Member-Scientific Board at Defymed SAS.
He previously worked as a Principal at bioMérieux SA.
Thierry Delair active positions
| Companies | Position | Start |
|---|---|---|
Defymed SAS
 Defymed SAS BiotechnologyHealth Technology Defymed SAS develops and markets implantable bio-artificial medical devices for therapeutic applications. Its products include MailPan, a bioartificial pancreas; and ExOlin, a physiological insulin delivery device. The company was founded by Severine Sigrist in March 2011 and is headquartered in Strasbourg, France. | Corporate Officer/Principal | - |
| Université Claude Bernard Lyon 1 | Corporate Officer/Principal | - |
Former positions of Thierry Delair
| Companies | Position | End |
|---|---|---|
| BIOMÉRIEUX | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| BIOMÉRIEUX | Health Technology |
| Private companies | 1 |
|---|---|
Defymed SAS
Defymed SAS BiotechnologyHealth Technology Defymed SAS develops and markets implantable bio-artificial medical devices for therapeutic applications. Its products include MailPan, a bioartificial pancreas; and ExOlin, a physiological insulin delivery device. The company was founded by Severine Sigrist in March 2011 and is headquartered in Strasbourg, France. | Health Technology |
- Stock Market
- Insiders
- Thierry Delair
